skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pharma Intelligence Logo
Search Icon Pharma Report StoreRecommendationsProduct loginProductLogin
Global Search Configuration

About Francesca

{6D506EDE-F0E4-4964-93FF-D8A3DA23BDA0}

+11 year(s) experience

Francesca Bruce
Francesca has been writing news and analysis relating to the pharmaceutical industry since 2008, paying special attention to market access developments across the world. Francesca regularly speaks to a range of stakeholders from across the sector to bring readers insights on key developments.
Francesca writes about a broad range of policy and regulatory topics, including intellectual property rights. However, her main areas of expertise are pricing and reimbursement and how medicines may or may not make it to patients. She writes about developments in Europe but is also expanding coverage in emerging markets, including Latin America and the Middle East. Francesca writes for Scrip, Pink Sheet and In Vivo.

Specialties

  • Policy & Regulation
  • Market Access
  • Pricing & Reimbursement

Francesca Writes For

Analyst Articles

Articles by Francesca